Magnesium Citrate

Description

Be Health Magnesium Citrate is a dietary supplement formulated to provide magnesium in the form of citrate. This product is presented in a lemon-flavored dosage form, designed for ease of consumption. Magnesium citrate is known for its bioavailability and is commonly used to support various physiological functions, including muscle and nerve function, as well as maintaining normal bone structure. The specific formulation and flavoring enhance the palatability of the supplement, making it suitable for individuals seeking to increase their magnesium intake.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces within a 24-hour timeframe, with a maximum of 3 fluid ounces allowed in that period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

The medication may be administered as a single daily dose or divided into multiple doses as deemed appropriate by the healthcare provider.

Contraindications

Use of this product is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these may indicate a serious underlying condition requiring medical evaluation.

Additionally, patients should consult a doctor or pharmacist prior to use if they are currently taking any other medications. It is advised to administer this product at least 2 hours before or after other drugs, as laxatives may alter the efficacy of concurrent medications.

Warnings and Precautions

Patients with a history of kidney disease should exercise caution when using this medication, as it may exacerbate their condition. Additionally, individuals on a magnesium-restricted diet must be aware of the potential for increased magnesium levels, which could lead to serious complications.

Abdominal pain, nausea, or vomiting may occur during treatment. If these symptoms arise, it is advisable to consult a healthcare professional. Furthermore, any sudden change in bowel habits that persists for more than two weeks warrants immediate medical evaluation, as it may indicate an underlying issue. Patients who have been using a laxative for longer than one week should also seek medical advice, as prolonged use can lead to dependency or other gastrointestinal complications.

In the event of an overdose, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay.

Patients should discontinue use and contact their healthcare provider if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may signify a serious medical condition that requires prompt attention.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions include the potential for kidney disease, which necessitates careful monitoring in patients with pre-existing conditions. Additionally, patients on a magnesium-restricted diet should exercise caution, as the medication may not be suitable for them.

Common adverse reactions reported include abdominal pain, nausea, and vomiting. Patients should be vigilant for any sudden changes in bowel habits that persist for more than two weeks, as this may indicate a need for medical evaluation. Furthermore, if patients have been using a laxative for longer than one week, they should consult a healthcare professional.

Patients are advised to stop use and seek medical attention if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms could signify a serious underlying condition. It is also important to note that the use of laxatives may interact with other medications, potentially affecting their efficacy. Therefore, patients should inform their healthcare provider of all medications they are taking to avoid adverse interactions.

Drug Interactions

Taking this product concurrently with other medications is not recommended. It is advised that this product be administered at least 2 hours before or after other drugs to minimize potential interactions.

Laxatives may alter the absorption and efficacy of concomitantly administered medications. Therefore, healthcare professionals should consider monitoring the therapeutic effects of other drugs when used alongside this product, particularly in patients who are also using laxatives. Adjustments to the dosage of other medications may be necessary based on clinical response and therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate (be health magnesium citrate oral solution - lemon). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a maximum dosage of 3 to 7 fluid ounces within a 24-hour period, with a strict limit of 7 fluid ounces. For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces in a 24-hour period, not exceeding 3 fluid ounces. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with kidney disease, it is essential to assess renal clearance to ensure appropriate therapeutic levels are maintained. Additionally, patients on a magnesium-restricted diet should be monitored closely, as renal impairment can affect magnesium levels and overall electrolyte balance. Regular evaluation of renal function is recommended to guide treatment decisions and minimize the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is important to note that there is no specific information regarding overdosage provided in the available sections of the drug insert.

Healthcare professionals are advised to monitor the patient closely for any potential symptoms that may arise, although specific symptoms related to overdosage have not been detailed.

Management of an overdosage should be supportive and symptomatic, as no specific antidote or treatment protocol is outlined. It is recommended that healthcare providers follow standard medical practices for managing overdose situations, including providing appropriate supportive care and monitoring vital signs.

In cases of suspected overdosage, consultation with a poison control center or a medical toxicologist may be beneficial for further guidance.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to understand the seriousness of this situation and act promptly.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after using the product, as these symptoms may indicate a serious underlying condition.

Patients are encouraged to discuss their current medications with their healthcare provider or pharmacist prior to using this product. This is crucial, as the use of laxatives may influence the effectiveness of other medications.

Additionally, patients should be informed to take this product at least 2 hours before or after taking any other drugs to minimize potential interactions and ensure optimal efficacy of all medications involved.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to ensure its stability and efficacy. Proper container requirements must be adhered to, and special handling needs should be observed to maintain the integrity of the product throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)